Desmosomal Cadherins and Signaling: Lessons from Autoimmune Disease

REFERENCES

• Amagai M, Stanley JR (2012). Desmoglein as a Target in Skin Disease and Beyond. J Invest Dermatol. 132: 776–784.
   PubMed Web of Science ®Google Scholar
• Aoyama Y, Kitajima Y (1999). Pemphigus vulgaris-IgG causes a rapid depletion of desmoglein 3 (Dsg3) from the Triton X-100 soluble pools, leading to the formation of Dsg3-depleted desmosomes in a human squamous carcinoma cell line, DJM-1 cells. J Invest Dermatol. 112: 67–71.
   PubMed Web of Science ®Google Scholar
• Bass-Zubek AE, Hobbs RP, Amargo EV, Garcia NJ, Hsieh SN, Chen X, Wahl JK III, Denning MF, Green KJ (2008). Plakophilin 2: a critical scaffold for PKCα that regulates intercellular junction assembly. J Cell Biol. 181: 605–613.
   PubMed Web of Science ®Google Scholar
• Bektas M, Jolly PS, Berkowitz P, Amagai M, Rubenstein DS (2013). A pathophysiologic role for epidermal growth factor receptor in pemphigus acantholysis. J Biol Chem. 288: 9447–9456.
   PubMed Web of Science ®Google Scholar
• Berkowitz P, Chua M, Liu Z, Diaz LA, Rubenstein DS (2008). Autoantibodies in the autoimmune disease pemphigus foliaceus induce blistering via p38 mitogen-activated protein kinase-dependent signaling in the skin. Am J Pathol. 173: 1628–1636.
   PubMed Web of Science ®Google Scholar
• Berkowitz P, Diaz LA, Hall RP, Rubenstein DS (2007). Induction of p38MAPK and HSP27 phosphorylation in pemphigus patient skin. J Invest Dermatol. 128: 738–740.
   PubMed Web of Science ®Google Scholar
• Berkowitz P, Hu P, Liu Z, Diaz LA, Enghild JJ, Chua MP, Rubenstein DS (2005). Desmosome signaling. Inhibition of p38MAPK prevents pemphigus vulgaris IgG-induced cytoskeleton reorganization. J Biol Chem. 280: 23778–23784.
   PubMed Web of Science ®Google Scholar
• Berkowitz P, Hu P, Warren S, Liu Z, Diaz LA, Rubenstein DS (2006). p38MAPK inhibition prevents disease in pemphigus vulgaris mice. Proc Natl Acad Sci U S A. 103: 12855–12860.
   PubMed Web of Science ®Google Scholar
• Brennan D, Hu Y, Medhat W, Dowling A, Mahoney MG (2010). Superficial Dsg2 Expression limits epidermal blister formation mediated by pemphigus foliaceus antibodies and exfoliative toxins. Dermatol Res Pract. 2010: 410278.
   PubMedGoogle Scholar
• Caldelari R, de Bruin A, Baumann D, Suter MM, Bierkamp C, Balmer V, Muller E (2001). A central role for the armadillo protein plakoglobin in the autoimmune disease pemphigus vulgaris. J Cell Biol. 153: 823–834.
   PubMed Web of Science ®Google Scholar
• Calkins CC, Setzer SV, Jennings JM, Summers S, Tsunoda K, Amagai M, Kowalczyk AP (2006). Desmoglein endocytosis and desmosome disassembly are coordinated responses to pemphigus autoantibodies. J Biol Chem. 281: 7623–7634.
   PubMed Web of Science ®Google Scholar
• Chen J, Nekrasova OE, Patel DM, Klessner JL, Godsel LM, Koetsier JL, Amargo EV, Desai BV, Green KJ (2012). The C-terminal unique region of desmoglein 2 inhibits its internalization via tail–tail interactions. J Cell Biol. 199: 699–711.
   PubMed Web of Science ®Google Scholar
• Chernyavsky AI, Arredondo J, Kitajima Y, Sato-Nagai M, Grando SA (2007). Desmoglein versus non-desmoglein signaling in pemphigus acantholysis: characterization of novel signaling pathways downstream of pemphigus vulgaris antigens. J Biol Chem. 282: 13804–13812.
   PubMed Web of Science ®Google Scholar
• Cirillo N, Lanza A, Prime SS (2010). Induction of hyper-adhesion attenuates autoimmune-induced keratinocyte cell-cell detachment and processing of adhesion molecules via mechanisms that involve PKC. Exp Cell Res. 316: 580–592.
   PubMed Web of Science ®Google Scholar
• Delva E, Jennings JM, Calkins CC, Kottke MD, Faundez V, Kowalczyk AP (2008). Pemphigus Vulgaris IgG-induced desmoglein-3 endocytosis and desmosomal disassembly are mediated by a clathrin- and dynamin-independent mechanism. J Biol Chem. 283: 18303–18313.
   PubMed Web of Science ®Google Scholar
• Di Zenzo G, Di Lullo G, Corti D, Calabresi V, Sinistro A, Vanzetta F, Didona B, Cianchini G, Hertl M, Eming R Amagai M, Ohyama B, Hashimoto T, Sloostra J, Sallusto F, Zambruno G, Lanzavecchia A (2012). Pemphigus autoantibodies generated through somatic mutations target the desmoglein-3 cis-interface. J Clin Invest. 122: 3781–3790.
   PubMed Web of Science ®Google Scholar
• Esaki C, Seishima M, Yamada T, Osada K, Kitajima Y (1995). Pharmacologic evidence for involvement of phospholipase C in pemphigus IgG-induced inositol 1,4,5-trisphosphate generation, intracellular calcium increase, and plasminogen activator secretion in DJM-1 cells, a squamous cell carcinoma line. J Invest Dermatol. 105: 329–333.
   PubMed Web of Science ®Google Scholar
• Frusic-Zlotkin M, Raichenberg D, Wang X, David M, Michel B, Milner Y (2006). Apoptotic mechanism in pemphigus autoimmunoglobulins-induced acantholysis–possible involvement of the EGF receptor. Autoimmunity. 39: 563–575.
   PubMed Web of Science ®Google Scholar
• Garrod D (2010). Desmosomes In Vivo. Dermatol Res Pract. 2010: 212439.
   PubMedGoogle Scholar
• Garrod DR, Berika MY, Bardsley WF, Holmes D, Tabernero L (2005). Hyper-adhesion in desmosomes: its regulation in wound healing and possible relationship to cadherin crystal structure. J Cell Sci. 118: 5743–5754.
   PubMed Web of Science ®Google Scholar
• Getsios S, Waschke J, Borradori L, Hertl M, Muller EJ (2010). From cell signaling to novel therapeutic concepts: international pemphigus meeting on advances in pemphigus research and therapy. J Invest Dermatol. 130: 1764–1768.
   PubMedGoogle Scholar
• Gil MP, Modol T, España A, López-Zabalza MJ (2012). Inhibition of FAK prevents blister formation in the neonatal mouse model of pemphigus vulgaris. Exp Dermatol. 21: 254–259.
   PubMed Web of Science ®Google Scholar
• Gliem M, Heupel W-M, Spindler V, Harms GS, Waschke J (2010). Actin reorganization contributes to loss of cell adhesion in pemphigus vulgaris. Am J Physiol Cell Physiol. 299: C606–C613.
   PubMed Web of Science ®Google Scholar
• Godsel LM, Dubash AD, Bass-Zubek AE, Amargo EV, Klessner JL, Hobbs RP, Chen X, Green KJ (2010). Plakophilin 2 couples actomyosin remodeling to desmosomal plaque assembly via RhoA. Mol. Biol. Cell. 21: 2844–2859.
   PubMed Web of Science ®Google Scholar
• Grando S (2012). Pemphigus autoimmunity: hypotheses and realities. Autoimmunity. 45: 7–35.
   PubMed Web of Science ®Google Scholar
• Heupel W-M, Engerer P, Schmidt E, Waschke J (2009a). Pemphigus vulgaris IgG cause loss of desmoglein-mediated adhesion and keratinocyte dissociation independent of epidermal growth factor receptor. Am J Pathol. 174: 475–485.
   PubMed Web of Science ®Google Scholar
• Heupel W-M, Müller T, Efthymiadis A, Schmidt E, Drenckhahn D, Waschke J (2009b). Peptides targeting the desmoglein 3 adhesive interface prevent autoantibody-induced acantholysis in pemphigus. J Biol Chem. 284: 8589–8595.
   PubMed Web of Science ®Google Scholar
• Heupel WM, Zillikens D, Drenckhahn D, Waschke J (2008). Pemphigus vulgaris IgG directly inhibit desmoglein 3-mediated transinteraction. J Immunol. 181: 1825–1834.
   PubMed Web of Science ®Google Scholar
• Hobbs RP, Green KJ (2012). Desmoplakin regulates desmosome hyperadhesion. J Invest Dermatol. 132: 482–485.
   PubMed Web of Science ®Google Scholar
• Iwatsuki K, Takigawa M, Imaizumi S, Yamada M (1989). In vivo binding site of pemphigus vulgaris antibodies and their fate during acantholysis. J Am Acad Dermatol. 20: 578–582.
   PubMed Web of Science ®Google Scholar
• Jolly PS, Berkowitz P, Bektas M, Lee H-E, Chua M, Diaz LA, Rubenstein DS (2010). p38MAPK signaling and desmoglein-3 internalization are linked events in pemphigus acantholysis. J Biol Chem. 285: 8936–8941.
   PubMed Web of Science ®Google Scholar
• Kimura TE, Merritt AJ, Garrod DR (2007). Calcium-independent desmosomes of keratinocytes are hyper-adhesive. J Invest Dermatol. 127: 775–781.
   PubMed Web of Science ®Google Scholar
• Kitajima Y (2013). New insights into desmosome regulation and pemphigus blistering as a desmosome-remodeling disease. Kaohsiung J Med Sci. 29: 1–13.
   PubMed Web of Science ®Google Scholar
• Kneisel A, Hertl M (2011). Autoimmune bullous skin diseases. Part 1: Clinical manifestations.J Dtsch Dermatol Ges. 9: 844–857.
   PubMed Web of Science ®Google Scholar
• Kröger C, Loschke F, Schwarz N, Windoffer R, Leube RE, Magin TM (2013). Keratins control intercellular adhesion involving PKC-α–mediated desmoplakin phosphorylation. J Cell Biol. 201: 681–692.
   PubMed Web of Science ®Google Scholar
• Lanza A, Cirillo N, Rossiello R, Rienzo M, Cutillo L, Casamassimi A, de Nigris F, Schiano C, Rossiello L, Femiano F Gombos F, Napoli C (2008). Evidence of key role of Cdk2 overexpression in pemphigus vulgaris. J Biol Chem. 283: 8736–8745.
   PubMed Web of Science ®Google Scholar
• Li N, Zhao M, Wang J, Liu Z, Diaz LA (2009). Involvement of the apoptotic mechanism in pemphigus foliaceus autoimmune injury of the skin. J Immunol. 182: 711–717.
   PubMed Web of Science ®Google Scholar
• Mao X, Choi EJ, Payne AS (2009). Disruption of desmosome assembly by monovalent human pemphigus vulgaris monoclonal antibodies. J Invest Dermatol. 129: 908–18.
   PubMed Web of Science ®Google Scholar
• Mao X, Li H, Sano Y, Gaestel M, Mo Park J, Payne AS (2013). MAPKAP Kinase 2 (MK2)-dependent and -independent models of blister formation in pemphigus vulgaris. J Invest Dermatol.
   Web of Science ®Google Scholar
• Mao X, Nagler AR, Farber SA, Choi EJ, Jackson LH, Leiferman KM, Ishii N, Hashimoto T, Amagai M, Zone JJ, Payne AS (2010). Autoimmunity to desmocollin 3 in pemphigus vulgaris. Am J Pathol. 177: 2724–2730.
   PubMed Web of Science ®Google Scholar
• Marchenko S, Chernyavsky AI, Arredondo J, Gindi V, Grando SA (2010). Antimitochondrial autoantibodies in pemphigus vulgaris. J Biol Chem. 285: 3695–3704.
   PubMed Web of Science ®Google Scholar
• Meng J-J, Bornslaeger EA, Green KJ, Steinert PM, Ip W (1997). Two-hybrid analysis reveals fundamental differences in direct interactions between desmoplakin and cell type-specific intermediate filaments. J Biol Chem. 272: 21495–21503.
   PubMed Web of Science ®Google Scholar
• Müller EJ, Williamson L, Kolly C, Suter MM (2008). Outside-in signaling through integrins and cadherins: a central mechanism to control epidermal growth and differentiation?J Invest Dermatol. 128: 501–516.
   PubMed Web of Science ®Google Scholar
• Nekrasova O, Green KJ (2013). Desmosome assembly and dynamics. Trends Cell Biol. 23: 537–546.
   PubMed Web of Science ®Google Scholar
• Nekrasova OE, Amargo EV, Smith WO, Chen J, Kreitzer GE, Green KJ (2011). Desmosomal cadherins utilize distinct kinesins for assembly into desmosomes. J Cell Biol. 195: 1185–1203.
   PubMed Web of Science ®Google Scholar
• Nguyen B, Dusek RL, Beaudry VG, Marinkovich MP, Attardi LD (2009). Loss of the desmosomal protein perp enhances the phenotypic effects of pemphigus vulgaris autoantibodies. J Invest Dermatol. 129: 1710–1718.
   PubMed Web of Science ®Google Scholar
• Oktarina DAM, van der Wier G, Diercks GFH, Jonkman MF, Pas HH (2011). IgG-induced clustering of desmogleins 1 and 3 in skin of patients with pemphigus fits with the desmoglein nonassembly depletion hypothesis. Br J Dermatol. 165: 552–562.
   PubMed Web of Science ®Google Scholar
• Osada K, Seishima M, Kitajima Y (1997). Pemphigus IgG activates and translocates protein kinase C from the cytosol to the particulate/cytoskeleton fractions in human keratinocytes. J Invest Dermatol. 108: 482–487.
   PubMed Web of Science ®Google Scholar
• Patel HP, Diaz LA, Anhalt GJ, Labib RS, Takahashi Y (1984). Demonstration of pemphigus antibodies on the cell surface of murine epidermal cell monolayers and their internalization. J Invest Dermatol. 83: 409–415.
   PubMed Web of Science ®Google Scholar
• Pretel M, España A, Marquina M, Beatriz Pelacho López-Picazo J, López-Zabalza J (2009). An imbalance in Akt/mTOR is involved in the apoptotic and acantholytic processes in a mouse model of pemphigus vulgaris. Exp Dermatol. 18: 771–780.
   PubMed Web of Science ®Google Scholar
• Rafei D, Müller R, Ishii N, Llamazares M, Hashimoto T, Hertl M, Eming R (2011). IgG autoantibodies against desmocollin 3 in pemphigus sera induce loss of keratinocyte adhesion. Am J Pathol. 178: 718–723.
   PubMed Web of Science ®Google Scholar
• Roetzer V, Waschke J, Spindler V (2013). Adducin modulates intercellular keratinocyte adhesion. FASEB J. 27: 650.15.
   Google Scholar
• Saito M, Stahley SN, Caughman CY, Mao X, Tucker DK, Payne AS, Amagai M, Kowalczyk AP (2012). Signaling dependent and independent mechanisms in pemphigus vulgaris blister formation. PLoS One. 7: e50696.
   PubMedGoogle Scholar
• Sato M, Aoyama Y, Kitajima Y (2000). Assembly pathway of desmoglein 3 to desmosomes and its perturbation by pemphigus vulgaris-IgG in cultured keratinocytes, as revealed by time-lapsed labeling immunoelectron microscopy. Lab Invest. 80: 1583–1592.
   PubMed Web of Science ®Google Scholar
• Schmidt E, Waschke J (2009). Apoptosis in pemphigus. Autoimmun Rev. 8: 533–537.
   PubMed Web of Science ®Google Scholar
• Schulze K, Galichet A, Sayar BS, Scothern A, Howald D, Zymann H, Siffert M, Zenhausern D, Bolli R, Koch PJ Garrod D, Suter MM, Müller EJ (2012). An adult passive transfer mouse model to study desmoglein 3 signaling in pemphigus vulgaris. J Invest Dermatol. 132: 346–355.
   PubMed Web of Science ®Google Scholar
• Seishima M, Esaki C, Osada K, Mori S, Hashimoto T, Kitajima Y (1995). Pemphigus IgG, but not bullous pemphigoid IgG, causes a transient increase in intracellular calcium and inositol 1,4,5-triphosphate in DJM-1 cells, a squamous cell carcinoma line. J Invest Dermatol. 104: 33–37.
   PubMed Web of Science ®Google Scholar
• Shu E, Yamamoto Y, Aoyama Y, Kitajima Y (2007). Intraperitoneal injection of pemphigus vulgaris-IgG into mouse depletes epidermal keratinocytes of desmoglein 3 associated with generation of acantholysis. Arch Derm Res. 299: 165–167.
   PubMed Web of Science ®Google Scholar
• Spindler V, Drenckhahn D, Zillikens D, Waschke J (2007). Pemphigus IgG causes skin splitting in the presence of both desmoglein 1 and desmoglein 3. Am J Pathol. 171: 906–16.
   PubMed Web of Science ®Google Scholar
• Spindler V, Endlich A, Hartlieb E, Vielmuth F, Schmidt E, Waschke J (2011). The extent of desmoglein 3 depletion in pemphigus vulgaris is dependent on Ca(2+)-induced differentiation: a role in suprabasal epidermal skin splitting?Am J Pathol. 179: 1905–16.
   Google Scholar
• Spindler V, Rotzer V, Dehner C, Kempf B, Gliem M, Radeva M, Hartlieb E, Harms GS, Schmidt E, Waschke J (2013). Peptide-mediated desmoglein 3 crosslinking prevents pemphigus vulgaris autoantibody-induced skin blistering. J Clin Invest. 123: 800–811.
   PubMed Web of Science ®Google Scholar
• Takahashi Y, Patel HP, Labib RS, Diaz LA, Anhalt GJ (1985). Experimentally induced pemphigus vulgaris in neonatal BALB/c mice: a time-course study of clinical, immunologic, ultrastructural, and cytochemical changes. J Invest Dermatol. 84: 41–6.
   PubMed Web of Science ®Google Scholar
• Thomason HA, Cooper NH, Ansell DM, Chiu M, Merrit AJ, Hardman MJ, Garrod DR (2012). Direct evidence that PKCα positively regulates wound re-epithelialization: correlation with changes in desmosomal adhesiveness. J Pathol. 227: 346–356.
   PubMed Web of Science ®Google Scholar
• Thomason HA, Scothern A, McHarg S, Garrod DR (2010). Desmosomes: adhesive strength and signalling in health and disease. Biochem J. 429: 419–433.
   PubMed Web of Science ®Google Scholar
• Tsang SM, Brown L, Gadmor H, Gammon L, Fortune F, Wheeler A, Wan H (2012a). Desmoglein 3 acting as an upstream regulator of Rho GTPases, Rac-1/Cdc42 in the regulation of actin organisation and dynamics. Exp Cell Res. 318: 2269–2283.
   PubMed Web of Science ®Google Scholar
• Tsang SM, Brown L, Lin K, Liu L, Piper K, O’Toole EA, Grose R, Hart IR, Garrod DR, Fortune F, Wan H (2012b). Non-junctional human desmoglein 3 acts as an upstream regulator of Src in E-cadherin adhesion, a pathway possibly involved in the pathogenesis of pemphigus vulgaris. J Pathol. 227: 81–93.
   PubMed Web of Science ®Google Scholar
• Wallis S, Lloyd S, Wise I, Ireland G, Fleming TP, Garrod D (2000). The alpha isoform of protein kinase C is involved in signaling the response of desmosomes to wounding in cultured epithelial cells. Mol Biol Cell. 11: 1077–1092.
   PubMed Web of Science ®Google Scholar
• Waschke J (2008). The desmosome and pemphigus. Histochem Cell Biol. 130: 21–54.
   PubMedGoogle Scholar
• Waschke J, Bruggeman P, Baumgartner W, Zillikens D, Drenckhahn D (2005). Pemphigus foliaceus IgG causes dissociation of desmoglein 1-containing junctions without blocking desmoglein 1 transinteraction. J Clin Invest. 115: 3157–3165.
   PubMed Web of Science ®Google Scholar
• Waschke J, Spindler V, Bruggeman P, Zillikens D, Schmidt G, Drenckhahn D (2006). Inhibition of Rho A activity causes pemphigus skin blistering. J Cell Biol. 175: 721–727.
   PubMed Web of Science ®Google Scholar
• Williamson L, Raess NA, Caldelari R, Zakher A, de Bruin A, Posthaus H, Bolli R, Hunziker T, Suter MM, Muller EJ (2006). Pemphigus vulgaris identifies plakoglobin as key suppressor of c-Myc in the skin. EMBO J. 25: 3298–309.
   PubMed Web of Science ®Google Scholar
• Windoffer R, Borchert-Stuhltrager M, Leube RE (2002). Desmosomes: interconnected calcium-dependent structures of remarkable stability with significant integral membrane protein turnover. J Cell Sci. 115: 1717–1732.
   PubMed Web of Science ®Google Scholar
• Yamagami J, Payne AS, Kacir S, Ishii K, Siegel DL, Stanley JR (2010). Homologous regions of autoantibody heavy chain complementarity-determining region 3 (H-CDR3) in patients with pemphigus cause pathogenicity. J Clin Invest. 120: 4111–4117.
   PubMed Web of Science ®Google Scholar
• Yamamoto Y, Aoyama Y, Shu E, Tsunoda K, Amagai M, Kitajima Y (2007). Anti-desmoglein 3 (Dsg3) Monoclonal antibodies deplete desmosomes of Dsg3 and differ in their Dsg3-depleting activities related to pathogenicity. J Biol Chem. 282: 17866–17876.
   PubMed Web of Science ®Google Scholar